@article{99cb7835db7a4628b1cf74879ee4fc17,
title = "PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma",
author = "Barbara Muz and Maurizio Buggio and Feda Azab and {De La Puente}, Pilar and Mark Fiala and Padval, {Mahesh V.} and Weaver, {David T.} and Pachter, {Jonathan A.} and Ravi Vij and Azab, {Abdel Kareem}",
note = "Funding Information: 1Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA; 2Nanomedicine Laboratory, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester ,UK; 3Department of Medicine, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA and 4Verastem Inc., Needham, MA, USA Funding: this study was supported partially by a research grant from Verastem, Inc. and by an award from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and the National Cancer Institute of the NIH under (U54CA199092). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.",
year = "2019",
month = jun,
day = "30",
doi = "10.3324/haematol.2018.194688",
language = "English (US)",
volume = "104",
pages = "e310--e313",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "7",
}